Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT02147067
Eligibility Criteria:
Inclusion Criteria:
* History of typical angina or effort-induced anginal symptoms and are currently experiencing angina at least once per week
* Abnormal stress ECG, exercise stress imaging, or pharmacological stress imaging
* Non-obstructive coronary artery disease as defined by lesion stenosis ≤ 50% in any artery as visualized by diagnostic angiography
Exclusion Criteria:
* Inability to provide informed consent
* Active Myocardial Infarction
* History of coronary artery bypass grafting
* Diagnosis of other specific cardiac disease such as severe valvular heart disease, cardiomyopathy, or variant angina
* Left Ventricular Ejection Fraction (LVEF) \< 30%
* Known renal insufficiency (CrCl \< 30 mL/min) or on dialysis
* Contraindications to the use of Ranolazine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02147067
Study Brief:
Protocol Section:
NCT02147067